Skip to search formSkip to main contentSkip to account menu

SRL172

Known as: SRL 172 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2004
Highly Cited
2004
BACKGROUND This open-label, randomised phase III study was designed to further investigate the clinical activity and safety of… 
2003
2003
We conducted a randomized phase II trial of SRL172 (Mycobacterium vaccae) ± low-dose interleukin-2 (IL-2) as treatment for stage… 
Highly Cited
2003
Highly Cited
2003
T-helper (Th)2 cytokines play a central role in asthma. Therefore, a double-blind randomised study was conducted to investigate… 
2002
2002
BACKGROUND SRL172 is a suspension of heat killed Mycobacterium vaccae, that has been found to be a potent immunological adjuvant… 
2002
2002
The objectives of this study were to determine the toxicity of intratumoural/intrapleural SRL172 in addition to intradermal… 
Highly Cited
2000
Highly Cited
2000
Mycobacterial preparations have been used with limited success against cancer apart from superficial bladder cancer. Recently, a… 
2000
2000
Periodontal disease is a bacterial dental plaque‐induced destructive inflammatory condition of the tooth‐supporting tissues… 
Highly Cited
1998
Highly Cited
1998
OBJECTIVE To assess whether a new heat-killed Mycobacterium vaccae preparation (SRL172), which enhances cell-mediated immunity… 
1998
1998
OBJECTIVE To evaluate the potential of heat-killed Mycobacterium vaccae (SRL172) as a nonspecific immunostimulant and as an…